Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Functional Status × Plasma cell × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1

Conditions

Multiple Myeloma 1

Interventions

Bortezomib 20 Blood Specimen Collection 9 Surveys and Questionnaires 8 Lenalidomide 8 Dexamethasone 8 pomalidomide 6 daratumumab 6 Flow Cytometry 6 Immunoenzyme Techniques 5 Biopsy 5 plerixafor 4 idecabtagene vicleucel 4 carfilzomib 4 Standard of Care 4 Polymerase Chain Reaction 4 Amplified Fragment Length Polymorphism Analysis 4 Specimen Handling 3 Psychiatric Rehabilitation 3 Microarray Analysis 3 Melphalan 3 Magnetic Resonance Spectroscopy 3 Interviews as Topic 3 Drug Therapy 3 Data Collection 3 Cytogenetic Analysis 3 Chromatin Immunoprecipitation Sequencing 3 talquetamab 2 selinexor 2 belantamab mafodotin 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05276622 2024-12-12

PaCE-MM

UNC Lineberger Comprehensive Cancer Center

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡